The activity of proapoptotic genes increases after renal ischemia/reperfusion


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

According to the World Health Organization, pathologies associated with ischemia/reperfusion occupy the leading position in the structure of mortality. The efficiency of localized kidney cancer surgery is limited by the damaging effects of prolonged warm ischemia and reperfusion. Ischemia/reperfusion damage to renal tissue may be related to changes in the expression profiles of pro- and antiapoptotic genes. Here, we have presented the longitudinal expression profiles of apoptosis-related genes in tissues of left and right (intact) kidneys of male rats exposed to unilateral ischemia followed by reperfusion. The profiles have been assessed at time points of 1, 3, and 48 h after the ischemic/reperfusion exposure by RT-qPCR quantification of mRNAs encoded by 13 genes, including BAX, p53, AIFM1, APAF1, CASP8, CASP3, CASP9, CASP7, MDM2, BCL2, CIAP1, XIAP, and ICAD, after normalization with respect to a reference gene ACTB. The study revealed a shift in the expression of pro- and antiapoptotic genes toward the predominance of proapoptotic processes, as was evinced by the increase in expression detected for the BAX, p53, AIFM1, APAF1, and CASP8 genes. One hour after the reperfusion, activation of mitochondrial, or intrinsic apoptosis was detected, while р53-dependent and extrinsic, i.e., receptor-driven, apoptosis joined at later time points. Changes in the level of expression of caspase 7 (CASP7)-encoding mRNA have only been detected 48 h after the restoration of blood flow. Changes have been observed in the transcription of pro- and antiapoptotic genes in tissues of both kidneys, which suggests the involvement of the contralateral kidney in systemic pathological process that develops during unilateral ischemia/reperfusion.

作者简介

O. Kit

Rostov Research Institute of Oncology

Email: dvodolazhsky@gmail.com
俄罗斯联邦, Rostov-on-Don, 344037

D. Vodolazhsky

Rostov Research Institute of Oncology

编辑信件的主要联系方式.
Email: dvodolazhsky@gmail.com
俄罗斯联邦, Rostov-on-Don, 344037

S. Dimitriadi

Rostov Research Institute of Oncology

Email: dvodolazhsky@gmail.com
俄罗斯联邦, Rostov-on-Don, 344037

D. Kutilin

Rostov Research Institute of Oncology

Email: dvodolazhsky@gmail.com
俄罗斯联邦, Rostov-on-Don, 344037

N. Timoshkina

Rostov Research Institute of Oncology

Email: dvodolazhsky@gmail.com
俄罗斯联邦, Rostov-on-Don, 344037

E. Gudueva

Rostov Research Institute of Oncology

Email: dvodolazhsky@gmail.com
俄罗斯联邦, Rostov-on-Don, 344037

E. Frantsiyants

Rostov Research Institute of Oncology

Email: dvodolazhsky@gmail.com
俄罗斯联邦, Rostov-on-Don, 344037

补充文件

附件文件
动作
1. JATS XML

版权所有 © Pleiades Publishing, Inc., 2017